| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.6M | — |
| Cost of Revenue | $1.4M | — |
| Gross Profit | $195K | — |
| R&D Expense | $15.9M | +150.5% |
| SG&A Expense | $43.1M | +366.6% |
| Operating Income | -$59.5M | -1359.3% |
| Pre-tax Income | -$298.7M | -1722.1% |
| Income Tax | -$160K | — |
| Net Income | -$297.6M | -3867.0% |
| EPS (Basic) | -$3.31 | -727.5% |
| EPS (Diluted) | -$3.31 | -727.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $359.9M | +2047.4% |
| Inventory | $18.5M | — |
| Current Assets | $385.4M | — |
| Total Assets | $695.0M | +2779.5% |
| Current Liabilities | $37.9M | +861.6% |
| Total Liabilities | $191.8M | +1022.2% |
| Stockholders' Equity | $494.3M | +3002.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.0M | -3402.5% |
| Investing Cash Flow | -$139.6M | -156.5% |
| Financing Cash Flow | $531.7M | +316.3% |